Robin L. Teskin has joined LeClairRyan as a shareholder on the firm’s Intellectual Property and Technology Practice Area team. She will be resident in the national law firm’s Alexandria office.
An experienced patent practitioner, Teskin focuses her practice on patent law in the biotechnology and pharmaceutical industries. Teskin’s over 25 years of experience includes all aspects of patent counseling and patent prosecution, including providing freedom-to-operate, due diligence, noninfringement and invalidity opinions. She advises a variety of clients, including start-up and established biotechnology and pharmaceutical companies and prominent research universities.
Teskin also offers clients a depth of experience handling complex post-issuance matters involving reissue, reexamination, opposition and interference proceedings. In addition, through her representation of a leading pharmaceutical company at the forefront of drug formulation research, she has developed an extensive background in Hatch-Waxman legal issues.
Prior to her admission to the bar, Teskin served as a patent examiner at the U.S. Patent and Trademark Office, where she was a member of the Biotechnology Group. She issued more than 450 patents dealing with complex biotechnology research and received a Bronze Medal for distinguished federal service.
A graduate of George Washington University Law School (J.D.), Stevens Institute of Technology (MChE), and Montclair State College (B.S., Biology and Chemistry), Robin is a member of the American Bar Association, District of Columbia Bar Association, Association of University Technology Managers, and Intellectual Property Owners Association. She is admitted to practice in the District of Columbia and Virginia and before the U.S. Patent and Trademark Office.
Also joining the Intellectual Property and Technology practice with Teskin are Dr. Kenneth J. Kalafus as an associate and Dr. Amy H. Bray as a law clerk (Bray is anticipated to become an associate upon successful completion of the July Virginia bar), as well as two IP assistants and a foreign docket specialist. All of these individuals have worked with Teskin and with clients whom Teskin represented for years at her previous firm.
“We are thrilled to have joined LeClairRyan given the firm’s considerable depth in life sciences and chemical patent prosecution and litigation, highly competitive rates, and the wealth of highly qualified attorneys and patent agents, very many with advanced technical degrees,” said Teskin. “We also look forward to being part of an IP group co-chaired by Mike Goldman and Laurin Mills and to have the opportunity to help grow the firm’s nationally-recognized and vibrant Post-Grant patent practice.”
